-The Hindu Deputy Commissioner asks officials to redouble efforts against illegal activities Gulbarga: Deputy Commissioner N.S. Prasanna Kumar on Wednesday reaffirmed that there would not be any let-up in the crackdown against illegal extraction and hoarding of sand and the district officials have been asked to redouble their efforts to put down such illegal activities. Talking to presspersons here, Mr. Prasanna Kumar said that 350 truckloads of sand illegally hoarded in open spaces...

-The Business Standard Drugs are unaffordable, but price control is the wrong answer There is little doubt that medicines in India are too expensive for most of the population. For the poorest 20 per cent of Indians, the expenditure on medicines alone is 85 per cent of what they spend on their health, according to the National Sample Survey. A World Bank study on the subject found that just out-of-pocket medical costs...

-The Business Standard Ranchi: Jharkhand could qualify for more funds than the Rs 1,500-crore earmarked as labour budget under MGNREGS, if the state pulled up its socks and honoured deadlines while executing the Centre's flagship scheme this fiscal. The word came from Union rural development minister Jairam Ramesh who reviewed the job programme and action plans for Saranda and Sarju areas among other things at the Project Building in Ranchi today. "Of the...

-The Economic Times Three weeks ago, when the Supreme Court reopened the iron-ore mining door some more in Karnataka, miners in Orissa breathed a Rs 50,000 crore sigh of relief. Also in the dock for some offences of a similar nature, Orissa's iron-ore miners, who produce a third of this mineral that is critical to steel, had been dreading their fate, which lay in the hands of a Central government panel. The...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...